BioCentury
ARTICLE | Finance

Fibrosis firsts

Why Cowen, Menlo chose Pliant as their first fibrosis investments

July 18, 2018 5:45 PM UTC

Pliant Therapeutics Inc.’s preclinical models and discovery technology prompted Cowen Healthcare Investments and Menlo Ventures to choose the company as their first fibrosis investments.

Cowen led Pliant’s untranched $62 million series B round on Monday, joined by fellow new investors Eventide Asset Management, Schroder Adveq, Menlo Ventures, S-Cubed Capital, Agent Capital and undisclosed institutional investors...